Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China · Delayed Price · Currency is CNY 10.31
+0.18 (1.78%)
Jan 23, 2026, 3:04 PM CST
SHE:300942 Revenue
Shenzhen Bioeasy Biotechnology had revenue of 76.35M CNY in the quarter ending September 30, 2025, with 40.34% growth. This brings the company's revenue in the last twelve months to 251.83M, up 1.93% year-over-year. In the year 2024, Shenzhen Bioeasy Biotechnology had annual revenue of 224.25M, down -11.75%.
Revenue (ttm)
251.83M
Revenue Growth
+1.93%
P/S Ratio
16.29
Revenue / Employee
524.66K
Employees
480
Market Cap
4.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 224.25M | -29.86M | -11.75% |
| Dec 31, 2023 | 254.11M | -432.79M | -63.01% |
| Jan 1, 2023 | 686.90M | 89.36M | 14.95% |
| Jan 1, 2022 | 597.54M | 339.08M | 131.20% |
| Dec 31, 2020 | 258.46M | 19.28M | 8.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.69B |
| Qingdao Vland Biotech INC. | 1.39B |
| Beijing Kawin Technology Share-Holding | 1.15B |
| Pulike Biological Engineering | 1.10B |
| Boji Medical Technology | 770.19M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Guanhao Biotech | 392.83M |
| Yantai Zhenghai Biotechnology | 347.60M |